ACADIA Pharmaceuticals Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (67)

Latest Posts

About This Stock More About This Stock
Stocks Slump On July 7 Closing At The Lows Of The Day
Article By: Michael J. Kramer
Tuesday, July 7, 2020 5:50 PM EDT
Stocks had a wild trading session, starting the morning lower, then rising, and finishing the session on the lows of the day, with the S&P 500 down over 1%.
In this article: ACAD, QQQ, INTC, NVDA, IEF, SPX
Read
Russell 2000 Retreats
Article By: Nick Santiago
Thursday, April 30, 2020 11:51 AM EDT
The Russell 2000 Index is pulling back today after hitting a major resistance level yesterday.
In this article: IWM Also: AME, GNRC, HAE, TREX, ACAD, RGEN, TDOC, NVCR, LITE, REXR
Read
The Bull Will Run Again, It Isn’t A Matter Of “If” But “When”
Article By: Michael J. Kramer
Saturday, February 29, 2020 12:27 PM EDT
Companies like Apple, Microsoft, Visa, Mastercard, and Tesla, which are all some of my largest holding by weightings, may see struggles in the short-term, six months or so, but are likely to rebound over the longer-term.
In this article: MA, V, ACAD, AAPL, MSFT, NFLX, TSLA
Read
Algo’s Search Ferociously For Levels And By Hook Or By Crook They Will Find It
Article By: Michael J. Kramer
Wednesday, February 26, 2020 7:55 AM EDT
It has been a wild overnight trading session, with the S&P 500 futures pointing to a flattish open at 3,126. The futures traded to as low as 3,091 and have bounced.
In this article: DEO, ACAD, NFLX, IEF, SPX, ROKU
Read
Biotech (Top Weights) Earnings Estimates And Revisions
Article By: T.J. Hayes
Friday, January 31, 2020 4:20 PM EDT
The cumulative 2020 earnings power of these 30 stocks was revised UP by 2.06% in the past 60 days.
In this article: SNY, ACAD, ALXN, ILMN, INCY, AMGN, BIIB, GILD, GH, BBIO, IBB
Read

PARTNER HEADLINES

Latest Tweets for $ACAD

No tweets yet!

$ACAD

Key Catalysts For ACADIA Pharmaceuticals
Isaac Pomerance 6/8/2020 3:46:48 AM

What do you think specifically has helped $ACAD thrive during the Pandemic? While they are focusing on the development of drugs unrelated to COVID-19, how were they able to thrive?

Sunday Trio Of Short Ideas
All Things Tech 8/28/2017 3:36:31 AM

100% agreement on $BWLD especially since it has been flat for months in a bullish market with more room to fall.

I disagree with $AMD. If AMD falls below the SMA200, absolutely short, but the Triple Bottom off 12.00 is a cause of concern + a previous ER beat + Q3 ER beat likely & sitting in oversold territory according to (MFI). $SOXX shows a Pennant as well.

$ACAD long-term is down, but short term is up. Above the SMA 20, 50 & 200.

Both AMD & ACAD is big risk little reward in my book unless the Days to Cover is a big enough window. Otherwise just not worth it in my book.

1 to 2 of 2 comments